PI Pharma Insight

BNF presentation directory

Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.

Reset

Active filters

  • Product: Rivastigmine
Presentation Product Chemical substance Chapter Items dispensed
Rivastigmine 3mg capsules
0411000E0AAABAB
Rivastigmine Rivastigmine Central Nervous System 24,210
Rivastigmine 9.5mg/24hours transdermal patches
0411000E0AAAGAG
Rivastigmine Rivastigmine Central Nervous System 23,359
Rivastigmine 1.5mg capsules
0411000E0AAAAAA
Rivastigmine Rivastigmine Central Nervous System 17,715
Rivastigmine 4.6mg/24hours transdermal patches
0411000E0AAAFAF
Rivastigmine Rivastigmine Central Nervous System 10,505
Rivastigmine 4.5mg capsules
0411000E0AAACAC
Rivastigmine Rivastigmine Central Nervous System 10,114
Rivastigmine 6mg capsules
0411000E0AAADAD
Rivastigmine Rivastigmine Central Nervous System 7,370
Rivastigmine 13.3mg/24hours transdermal patches
0411000E0AAAIAI
Rivastigmine Rivastigmine Central Nervous System 5,429
Rivastigmine 2mg/ml oral solution sugar free
0411000E0AAAEAE
Rivastigmine Rivastigmine Central Nervous System 916
Rivastigmine 2mg/ml oral solution
0411000E0AAAHAH
Rivastigmine Rivastigmine Central Nervous System 1

Why monitor BNF codes?

Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.

Track cost pressure

Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.

Understand demand drivers

Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.